April 11, 2025 - 21:20

Hamamatsu Photonics has announced a significant strategic partnership with Sirona Dx (SDX) aimed at expanding their Technology Access Program (TAP). This collaboration is set to enhance the accessibility of cutting-edge imaging and proteomics solutions, which are crucial for advancing research and diagnostics in various fields.
The partnership will leverage Hamamatsu's expertise in whole slide imaging and spatial proteomics, enabling researchers and healthcare professionals to benefit from innovative technologies that improve diagnostic accuracy and efficiency. By combining resources and knowledge, both companies aim to drive advancements in the medical and research communities.
This initiative is expected to facilitate better access to high-quality imaging tools, ultimately leading to improved patient outcomes and accelerated scientific discovery. The collaboration reflects a commitment to fostering innovation and ensuring that state-of-the-art technology is available to a broader audience, paving the way for future breakthroughs in healthcare and research.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...